FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinson's Disease Patients

Article Link: FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinson’s Disease Patients



Source: FDA New Drug Approvals